1227692-67-2

Basic information

• Product Name: 5-((3,5-dichlorophenoxy)methyl)-1H-pyrazol-3(2H)-one
• Synonyms: 5-((3,5-dichlorophenoxy)methyl)-1H-pyrazol-3(2H)-one
• CAS NO: 1227692-67-2
• Molecular Weight: 259.092
• Mol File: 1227692-67-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-((3,5-dichlorophenoxy)methyl)-1H-pyrazol-3(2H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-((3,5-dichlorophenoxy)methyl)-1H-pyrazol-3(2H)-one(1227692-67-2)
• EPA Substance Registry System: 5-((3,5-dichlorophenoxy)methyl)-1H-pyrazol-3(2H)-one(1227692-67-2)

Safety Data

• Hazardous Substances Data: 1227692-67-2(Hazardous Substances Data)

Upstream product

• 1226145-00-1 ethyl 4-(3,5-dichlorophenoxy)-3-oxobutanoate 
• 55502-54-0 3,5-dichlorophenoxyacetyl chloride 
• 587-64-4 2-(3,5-dichlorophenoxy)acetic acid 
• 591-35-5 3,5-dichlorophenol 
• 638-07-3 ethyl (2-chloroaceto)acetate 
• 1227692-21-8 2-(3,5-dichlorophenoxy)-N-methoxy-N-methylacetamide 
• 119024-29-2 ethyl 2-(3,5-dichlorophenoxy)acetate 

Relevant articles and documents

Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1

Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal neurodegenerative disease. Although the cause remains unknown, misfolded protein aggregates are seen in neurons of sporadic ALS patients, and familial ALS mutations, including mutations in su

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided compounds.